Back

Hypertrophic cardiomyopathy: from risk stratification to management of the obstructive component, SAC guidelines: Panel Discussion

15 October 2026 (16:35 - 17:00)
Organised by:
Seminar Presentation Part of: Heart failure and cardiomyopathy Chronic Heart Failure Open Access ESC in LATAM 2026

3 More presentations in this session

Presentation thumbnail
Heart failure and cardiomyopathy: contributions from the new 2026 ESC guidelines
Presentation thumbnail
Heart failure and cardiomyopathy: contributions from the new 2026 ESC guidelines: Panel Discussion
Presentation thumbnail
Hypertrophic cardiomyopathy: from risk stratification to management of the obstructive component, SAC guidelines

Access the full session

Session thumbnail
Heart failure and cardiomyopathy

The Event

Event poster

ESC in LATAM 2026

15 October 2026 16:35 CET
You may be interested in
thumbnail
Webinar
The spectrum of management options for the left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
28 October 2020
thumbnail
Congress Presentation
Sudden cardiac death: assessing who is at risk.
26 August 2022
thumbnail
Congress Presentation
Cardiac myosin inhibitors use in the real world: what you need to know
30 August 2025
thumbnail
Webinar
Hypertrophic cardiomyopathy: perspectives of the specialist and non-specialist in a healthcare environment
7 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources